Stuart P. Turner
University of Adelaide
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stuart P. Turner.
Hypertension | 2009
Christine J. Ball; David Wilson; Stuart P. Turner; David A. Saint; John F. Beltrame
Clinical studies suggest that T-type Ca2+ channel blockade may have incremental benefits over conventional L-channel blockade, particularly in microvascular disorders. This study examined functional vasomotor differences in L- and T-channel blockade between large and small vessels and compared the abundance of the L- and T-type channels in these vessels. The inhibition of endothelin-1 and potassium-induced vascular contractile responses by L-channel blockers (verapamil and nifedipine) was compared with combined L- and T-channel blockers (mibefradil and efonidipine) in large (rat aorta) and small (rat mesenteric and human subcutaneous) vessels using wire myography. All 4 of the Ca2+ channel blockers inhibited contractile responses to a similar extent in large rat vessels; however, in rat microvessels, the combined L- and T-channel blockers produced significantly greater inhibition of contraction than L-channel blockers alone. The significance of this differential T-channel effect in microvessels was further supported by the following: (1) a greater abundance of T-channels compared with L-channels in microvessels but not in large vessels; (2) demonstration of divergent Ca2+ channel blocker responses in human microvessels; (3) incremental inhibition of constrictor responses with combined L- and T-Ca2+ channel blockers despite maximal L-channel blockade; (4) the use of structurally diverse Ca2+ channel blockers with varied affinity for L- and T-channels; (5) the use of pharmacodynamically and therapeutically appropriate Ca2+ channel blocker concentrations; (6) confirmation of contractile agonist independent responses; and (7) exclusion of an endothelium-dependent mechanism. We propose that T-type channels play an important role in regulating contractile responses in the microvasculature and, therefore, are a potential therapeutic target.
Hypertension | 2009
David Wilson; Christine J. Ball; Stuart P. Turner; David A. Saint; John F. Beltrame
We acknowledge and endorse the comments made by Godfraind1 that the response to Ca2+ channel blockers is multifactorial. However, our data indicate that regional differences in Ca2+ L- and T-channel abundance may be important additional mechanisms that account for differential responses to Ca2+ channel blockers. Data from our previous and …
Journal of the American College of Cardiology | 2004
John F. Beltrame; Stuart P. Turner; Sue Leslie; Patty Solomon; S. B. Freedman; John D. Horowitz
Journal of The American Society of Echocardiography | 2004
Doan T.M. Ngo; Ronald D. Wuttke; Stuart P. Turner; Thomas H. Marwick; John D. Horowitz
American Journal of Cardiology | 2001
John F. Beltrame; Stuart P. Turner; John D. Horowitz
American Heart Journal | 2003
John F. Beltrame; Stuart P. Turner; Sue Leslie; John D. Horowitz
/data/revues/14439506/v12i2/S1443950603902058/ | 2011
John F. Beltrame; Stuart P. Turner; Susan Leslie; Patty Solomon; S. B. Freedman; John D. Horowitz
Archive | 2010
John D. Horowitz; John F. Beltrame; Stuart P. Turner; Susan Leslie; Patricia J. Solomon; Saul Benedict Freedman
Heart Lung and Circulation | 2003
Stuart P. Turner; John F. Beltrame; Michael B. Taylor; John D. Horowitz